Sahgal Arjun, Soliman Hany, Larson David A
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Prog Neurol Surg. 2012;25:82-95. doi: 10.1159/000331179. Epub 2012 Jan 6.
The purpose of this report was to review the role of whole brain radiotherapy (WBRT) in the management of brain metastases. In particular, we review the role of WBRT as a prophylactic therapy, and the role of surgery and stereotactic radiousurgery (SRS) with respect to WBRT, by discussing the relevant randomized controlled trials. WBRT is associated with toxicities and this may influence the decision to use WBRT and, therefore, we review both the acute side effects of WBRT and the more serious late side effects of neurocognitive impairment and leukoencephalopathy. As patients are living longer with brain metastases the role of WBRT is moving forward; however, using modern radiation technology we may be able to reduce the morbidity of this therapy. We present an extreme case of re-re-treatment WBRT with hippocampal sparing and simultaneous integrated boosts to multiple lesions as one of the future directions under evaluation.
本报告的目的是回顾全脑放疗(WBRT)在脑转移瘤治疗中的作用。特别是,我们通过讨论相关随机对照试验,回顾WBRT作为预防性治疗的作用,以及手术和立体定向放射外科(SRS)相对于WBRT的作用。WBRT存在毒性,这可能会影响使用WBRT的决策,因此,我们回顾了WBRT的急性副作用以及更严重的迟发性副作用,即神经认知障碍和白质脑病。随着脑转移瘤患者生存期的延长,WBRT的作用也在不断发展;然而,使用现代放射技术,我们或许能够降低这种治疗的发病率。我们展示了一例采用海马体保护和对多个病灶同时进行同步整合加量的WBRT再治疗极端病例,作为正在评估的未来方向之一。